Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow Reinvestment Rate
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Reinvestment Rate of 1.37x as of December 2024, reinvesting CN¥140.48 Million (capex CN¥83.91 Million plus investments CN¥-56.57 Million) from operating cash flow of CN¥102.67 Million. Check 301089 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 6 annual periods. Explore 301089 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For live market cap and broader valuation context, see market value of Xinxiang Tuoxin Pharmaceutical Co.Ltd..
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.37x | CN¥140.48 Million | CN¥102.67 Million | CN¥83.91 Million | ▼ -84.7% |
| 2023 | 8.97x | CN¥241.79 Million | CN¥26.95 Million | CN¥185.22 Million | ▲ +676.1% |
| 2022 | 1.16x | CN¥310.74 Million | CN¥268.85 Million | CN¥148.33 Million | ▼ -84.6% |
| 2021 | 7.48x | CN¥435.46 Million | CN¥58.19 Million | CN¥112.73 Million | ▲ +508.7% |
| 2020 | 1.23x | CN¥147.51 Million | CN¥120.00 Million | CN¥74.12 Million | ▼ -32.1% |
| 2019 | 1.81x | CN¥156.36 Million | CN¥86.38 Million | CN¥76.20 Million | — |